Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites

被引:16
作者
Covarrubias, Vanessa Gonzalez
Lakhman, Sukhwinder S.
Forrest, Alan
Relling, Mary V.
Blanco, Javier G.
机构
[1] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Dept Pharm Practice, Buffalo, NY 14260 USA
[3] St Jude Childrens Hosp, Memphis, TN 38105 USA
[4] Roswell Pk Canc Inst, Therapeut Program, Buffalo, NY 14263 USA
关键词
carbonyl reductase NAD(P)H : quinone oxidoreductase; ethnicity; genotype; liver; menadione; quinones;
D O I
10.1016/j.toxlet.2006.01.004
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In human liver, the two-electron reduction of quinone compounds, such as menadione is catalyzed by cytosolic carbonyl reductase (CBR) and NAD(P)H:quinone oxidoreductase (NQO1) activities. We assessed the relative contributions of CBR and NQO1 activities to the total menadione reducing capacity in liver cytosols from black (n = 31) and white donors (n = 63). Maximal menadione reductase activities did not differ between black (13.0 +/- 5.0 nmol/min mg), and white donors (11.4 +/- 6.6 nmol/min mg; p=0.208). In addition, both groups presented similar levels of CBR activities (CBRblacks = 10.9 +/- 4.1 nmol/min mg) versus CBRwhites=10.5 +/- 5.8 nmol/min mg; p=0.708). In contrast, blacks showed higher NQO1 activities (two-fold) than whites (NQO1(blacks) = 2.1 +/- 3.0 nmol/min mg versus NQO1(whites) =0.9 +/- 1.6 nmol/min mg, p < 0.01). To further explore this disparity, we tested whether NQO1 activity was associated with the common NQOI*2 genetic polymorphism by using paired DNA samples for genotyping. Cytosolic NQO1 activities differed significantly by NQO1 genotype status in whites (NQO1(whites[NQO1*1/*1]) = 1.3 +/- 1.7 nmol/min mg versus NQO1(whites[NQO1*1/*2+NQO1*2/*2]) = 0.5 +/- 0.7 nmol/min mg, p < 0.01), but not in blacks NQO1blacks[NQO1*1/*1] = 2.6 +/- 3.4 nmol/min mg versus (NQO1(blacks[NQO1*1/*2]) = 1.1 +/- 1.2 nmol/min mg, p = 0.134). Our findings pinpoint the presence of significant interethnic differences in polymorphic hepatic NQO1 activity. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:249 / 258
页数:10
相关论文
共 40 条
[1]  
Asher G, 2004, METHOD ENZYMOL, V382, P278
[2]  
Bello RI, 2004, METHOD ENZYMOL, V382, P234
[3]   INCREASE OF NAD(P)H-QUINONE REDUCTASE BY DIETARY ANTIOXIDANTS - POSSIBLE ROLE IN PROTECTION AGAINST CARCINOGENESIS AND TOXICITY [J].
BENSON, AM ;
HUNKELER, MJ ;
TALALAY, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09) :5216-5220
[4]   Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies [J].
Blanco, JG ;
Edick, MJ ;
Hancock, ML ;
Winick, NJ ;
Dervieux, T ;
Amylon, MD ;
Bash, RO ;
Behm, FG ;
Camitta, BM ;
Pui, CH ;
Raimondi, SC ;
Relling, MV .
PHARMACOGENETICS, 2002, 12 (08) :605-611
[5]   The importance of race and ethnic background in biomedical research and clinical practice [J].
Burchard, EG ;
Ziv, E ;
Coyle, N ;
Gomez, SL ;
Tang, H ;
Karter, AJ ;
Mountain, JL ;
Pérez-Stable, EJ ;
Sheppard, D ;
Risch, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1170-1175
[6]   Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function [J].
Cardillo, C ;
Kilcoyne, CM ;
Cannon, RO ;
Panza, JA .
CIRCULATION, 1999, 99 (01) :90-95
[7]   Pharmacogenetics and geographical ancestry: implications for drug development and global health [J].
Daar, AS ;
Singer, PA .
NATURE REVIEWS GENETICS, 2005, 6 (03) :241-246
[8]   Moving towards individualized medicine with pharmacogenomics [J].
Evans, WE ;
Relling, MV .
NATURE, 2004, 429 (6990) :464-468
[9]   Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C [J].
Fleming, RA ;
Drees, J ;
Loggie, BW ;
Russell, GB ;
Geisinger, KR ;
Morris, RT ;
Sachs, D ;
McQuellon, RP .
PHARMACOGENETICS, 2002, 12 (01) :31-37
[10]   Carbonyl reductase [J].
Forrest, GL ;
Gonzalez, B .
CHEMICO-BIOLOGICAL INTERACTIONS, 2000, 129 (1-2) :21-40